The Europe Portable Ultrasound Bladder Scanner Market would witness market growth of 3.5% CAGR during the forecast period (2024-2031). In the year 2021, the Europe market's volume surged to 8.64 Quintal, showcasing a growth of 2.8% (2020-2023).
The Germany market dominated the Europe Portable Ultrasound Bladder Scanner Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of$23.20 million by 2031. The UK market is exhibiting a CAGR of 2.6% during (2024 - 2031). Additionally, The France market would experience a CAGR of 4.4% during (2024 - 2031).
In clinical scenarios where catheterization is necessary, such as perioperative care or acute urinary retention, portable ultrasound bladder scanners provide valuable guidance for ensuring appropriate catheter placement and monitoring bladder decompression. This helps to decrease the risk of complications associated with catheter insertion, such as trauma to the urethra or bladder, and ensures optimal patient comfort and safety.
Likewise, to preserve hemodynamic stability and avoid consequences like fluid overload or dehydration, critically ill patients in intensive care units (ICUs) need careful fluid management. Portable ultrasound bladder scanners aid clinicians in assessing fluid status by monitoring changes in bladder volume and guiding fluid resuscitation strategies. This allows for more precise fluid titration and helps prevent adverse events associated with fluid imbalance.
Bladder cancer is one of the most common cancers in Europe, with a significant burden on healthcare systems. Improving patient outcomes and survival rates requires early identification. The high prevalence of bladder cancer in Europe drives the demand for portable bladder scanners as essential diagnostic tools for urological evaluations. Also, governments and healthcare providers allocate resources towards improving cancer detection and treatment. This drives market growth for advanced diagnostic equipment, including portable ultrasound bladder scanners. In conclusion, the region's rising rates of balder cancer drive the market's growth.
Based on Product, the market is segmented into 2D and 3D. Based on End-use, the market is segmented into Hospitals, Diagnostic Imaging Centers, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Portable Ultrasound Bladder Scanner Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of$23.20 million by 2031. The UK market is exhibiting a CAGR of 2.6% during (2024 - 2031). Additionally, The France market would experience a CAGR of 4.4% during (2024 - 2031).
In clinical scenarios where catheterization is necessary, such as perioperative care or acute urinary retention, portable ultrasound bladder scanners provide valuable guidance for ensuring appropriate catheter placement and monitoring bladder decompression. This helps to decrease the risk of complications associated with catheter insertion, such as trauma to the urethra or bladder, and ensures optimal patient comfort and safety.
Likewise, to preserve hemodynamic stability and avoid consequences like fluid overload or dehydration, critically ill patients in intensive care units (ICUs) need careful fluid management. Portable ultrasound bladder scanners aid clinicians in assessing fluid status by monitoring changes in bladder volume and guiding fluid resuscitation strategies. This allows for more precise fluid titration and helps prevent adverse events associated with fluid imbalance.
Bladder cancer is one of the most common cancers in Europe, with a significant burden on healthcare systems. Improving patient outcomes and survival rates requires early identification. The high prevalence of bladder cancer in Europe drives the demand for portable bladder scanners as essential diagnostic tools for urological evaluations. Also, governments and healthcare providers allocate resources towards improving cancer detection and treatment. This drives market growth for advanced diagnostic equipment, including portable ultrasound bladder scanners. In conclusion, the region's rising rates of balder cancer drive the market's growth.
Based on Product, the market is segmented into 2D and 3D. Based on End-use, the market is segmented into Hospitals, Diagnostic Imaging Centers, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Verathon Inc. (Roper Technologies, Inc.)
- Infinium Medical, Inc.
- Advin Health Care
- Caresono Technology Co.,Ltd.
- Becton, Dickinson and Company
- ECHO-SON S.A.
- Vitacon AS
Market Report Segmentation
By Product- 2D
- 3D
- Hospitals
- Diagnostic Imaging Centers
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Portable Ultrasound Bladder Scanner Market by Product
Chapter 5. Europe Portable Ultrasound Bladder Scanner Market by End-use
Chapter 6. Europe Portable Ultrasound Bladder Scanner Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Verathon Inc. (Roper Technologies, Inc.)
- Infinium Medical, Inc.
- Advin Health Care
- Caresono Technology Co.,Ltd.
- Becton, Dickinson and Company
- ECHO-SON S.A.
- Vitacon AS
Methodology
LOADING...
